Paul Prather Institution-verified
Sourced from institutional research profiles (UAMS TRI or ARA).
Professor
faculty
Pharmacology & Toxicology, College of Medicine
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Paul Prather, a Professor in Pharmacology & Toxicology at the University of Arkansas for Medical Sciences, directs federal grant-funded training programs focused on systems pharmacology and toxicology. He has served as Principal Investigator (PI) for two awards from the NIH/National Institute of General Medical Sciences, totaling $343,205. These grants, "Systems Pharmacology and Toxicology Training Program" ($168,193) and "Training in Systems Pharmacology and Toxicology (T-SPaT)" ($175,012), support educational initiatives within these specialized fields. Prather maintains an active laboratory website, suggesting ongoing research and engagement in the scientific community.
Federal Grants 2 $343,205 total
Grants & Funding
- Selective CB2 Cannabinoid Agonists as Candidate Therapeutics for Amyotrophic Lateral Sclerosis (ALS) ALS Association Principal Investigator
- Selective CB2 Cannabinoid Agonists as Candidate Therapeutics for ALS NIH Principal Investigator
- ABI P. Prather NIH T32 FY26 Y3 State of Arkansas Principal Investigator
- Systems Pharmacology and Toxicology Training Program NIH Principal Investigator
- OPIOID CONTROL MECHANISMS OF SIGNAL TRANSDUCTION NIH Principal Investigator
- CANNABINOID AGONIST REGULATION OF SIGNAL TRANSDUCTION NIH Principal Investigator
- Synthetic Cannabinoid Toxicity: Role of Biotransformation NIH Principal Investigator
- Use of precision deuteration to determine the contribution of norbuprenorphine to buprenorphine-associated neonatal abstinence syndrome NIH Co-Investigator
Frequent Collaborators
Similar Researchers
Based on overlapping research topics